|
Synonyms: hu1D9 | MLN-1202 | MLN1202
Compound class:
Antibody
Comment: Plozalizumab is a humanised anti-CCR2 monoclonal antibody, being investigated for its anti-inflammatory actions [2].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide analysis using the heavy and light chain variable amino acid sequences submitted with the INN record for plozalizumab, identifies 100% matches with sequences from patent US6696550 B2 [2]. 
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
Classification  |
|
| Compound class | Antibody |
| International Nonproprietary Names |
|
| INN number | INN |
| 10124 | plozalizumab |
| Synonyms |
| hu1D9 | MLN-1202 | MLN1202 |
| Database Links |
|
| Specialist databases | |
| GPCRdb Ligand | plozalizumab |
| IMGT/mAb-DB | 566 |
| Other databases | |
| GtoPdb PubChem SID | 310264702 |
| Search PubMed clinical trials | plozalizumab |
| Search PubMed titles | plozalizumab |
| Search PubMed titles/abstracts | plozalizumab |
